Feasibility of electromagnetic transponder use to monitor inter- and intrafractional motion in locally advanced pancreatic cancer patients

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages 566-573

  Shinohara, Eric T ^a   Kassaee, Alireza ^b   Mitra, Nandita ^b   Vapiwala, Neha ^b   Plastaras, John P ^b   Drebin, Jeff ^b   Wan, Fei ^b   Metz, James M ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Calypso; Organ motion; Pancreatic neoplasms; Radiation

Indexed keywords

CALYPSO; CLINICAL TRIAL; ELECTROMAGNETIC TRANSPONDERS; INTRAFRACTIONAL MOTION; LOCALIZATION AND TRACKING; MEAN SHIFT; METASTATIC DISEASE; ORGAN MOTION; P-VALUES; PANCREATIC CANCERS; PANCREATIC NEOPLASMS; PRIMARY OBJECTIVE; STANDARD DEVIATION; TARGET MOTIONS; TRACKING MODE; TUMOR MOTION;

DIAGNOSIS; DISEASES; ELECTROMAGNETISM; ENZYME INHIBITION; HEAT RADIATION; TUMORS; VECTOR QUANTIZATION;

TRANSPONDERS;

ADVANCED CANCER; ARTICLE; BREATH HOLDING; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ELECTROMAGNETIC RADIATION; ELECTROMAGNETIC TRANSPONDER IMPLANTATION; FEASIBILITY STUDY; HUMAN; IMPLANTATION; LAPAROSCOPY; ORTHOGONAL ROTATION; PANCREAS CANCER; PRIORITY JOURNAL;

ANATOMIC LANDMARKS; DOSE FRACTIONATION; ELECTROMAGNETIC FIELDS; FEASIBILITY STUDIES; FIDUCIAL MARKERS; HUMANS; MOVEMENT; PANCREATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOTHERAPY, CONFORMAL; RESPIRATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861100865     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.07.025     Document Type: Article

References (36)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. V. Pugliese, S. Saccomanno, and L. Bonelli Cancer of the pancreas: Clinical outcome in 76 cases Tumori 72 1986 601 607 (Pubitemid 17234824)
3. D. Li, K. Xie, and R. Wolff Pancreatic cancer Lancet 363 2004 1049 1057 (Pubitemid 38410779)
4. M. Trede The surgical treatment of pancreatic carcinoma Surgery 97 1985 28 35 (Pubitemid 15244873)
5. F. Michelassi, F. Erroi, and P.J. Dawson Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct Ann Surg 210 1989 544 554 discussion 554-546
6. S. Mukherjee, E. Hudson, and S. Reza Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer Clin Oncol (R Coll Radiol) 20 2008 535 540
7. C.G. Moertel, S. Frytak, R.G. Hahn Gastrointestinal Tumor Study Group Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil Cancer 48 1981 1705 1710 (Pubitemid 11022870)
8. Gastrointestinal Tumor Study Group Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma Cancer 56 1985 2563 2568
9. B. Chauffert, F. Mornex, and F. Bonnetain Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study Ann Oncol 19 2008 1592 1599
10. Gastrointestinal Tumor Study Group Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 1988 751 755
11. D.J. Klaassen, J.M. MacIntyre, and G.E. Catton Treatment of locally unresectable cancer of the stomach and pancreas: A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil - an Eastern Cooperative Oncology Group study J Clin Oncol 3 1985 373 378 (Pubitemid 15132005)
12. D.S. Shewach, T.M. Hahn, and E. Chang Metabolism of 2′,2′- difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells Cancer Res 54 1994 3218 3223
13. M. Fuss, A. Wong, and C.D. Fuller Image-guided intensity-modulated radiotherapy for pancreatic carcinoma Gastrointest Cancer Res 1 2007 2 11
14. E. Ben-Josef, A.F. Shields, and U. Vaishampayan Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer Int J Radiat Oncol Biol Phys 59 2004 454 459 (Pubitemid 38622600)
15. D. Schellenberg, K.A. Goodman, and F. Lee Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 72 2008 678 686
16. A.C. Koong, Q.T. Le, and A. Ho Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 58 2004 1017 1021 (Pubitemid 38314781)
17. A. Zurlo, A. Lomax, and A. Hoess The role of proton therapy in the treatment of large irradiation volumes: A comparative planning study of pancreatic and biliary tumors Int J Radiat Oncol Biol Phys 48 2000 277 288 (Pubitemid 30488240)
18. D.C. Hsiung-Stripp, J. McDonough, and H.M. Masters Comparative treatment planning between proton and X-ray therapy in pancreatic cancer Med Dosim 26 2001 255 259 (Pubitemid 33026413)
19. K.R. Kozak, L.A. Kachnic, and J. Adams Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment Int J Radiat Oncol Biol Phys 68 2007 1557 1566 (Pubitemid 47176818)
20. M. Feng, J.M. Balter, and D. Normolle Characterization of pancreatic tumor motion using cine MRI: Surrogates for tumor position should be used with caution Int J Radiat Oncol Biol Phys 74 2009 884 891
21. A.Y. Minn, D. Schellenberg, and P. Maxim Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment Am J Clin Oncol 32 2009 364 368
22. Y.G. van der Geld, B. van Triest, and W.F. Verbakel Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma Int J Radiat Oncol Biol Phys 72 2008 1215 1220
23. S. Gwynne, L. Wills, and G. Joseph Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer Clin Oncol (R Coll Radiol) 21 2009 713 719
24. P. Jayachandran, A.Y. Minn, and J. Van Dam Interfractional uncertainty in the treatment of pancreatic cancer with radiation Int J Radiat Oncol Biol Phys 76 2010 603 607
25. M.J. Murphy, D. Martin, and R. Whyte The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery Int J Radiat Oncol Biol Phys 53 2002 475 482 (Pubitemid 34522113)
26. D.P. Gierga, G.T. Chen, and J.H. Kung Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions Int J Radiat Oncol Biol Phys 58 2004 1584 1595 (Pubitemid 38438324)
27. R. Littell, G. Milliken, and W. Stroup SAS for mixed models Second ed. 2006 SAS Institute Cary, NC
28. B. Bussels, L. Goethals, and M. Feron Respiration-induced movement of the upper abdominal organs: A pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer Radiother Oncol 68 2003 69 74 (Pubitemid 37289338)
29. P.J. Bryan, S. Custar, and J.R. Haaga Respiratory movement of the pancreas: An ultrasonic study J Ultrasound Med 3 1984 317 320 (Pubitemid 14055576)
30. I. Suramo, M. Paivansalo, and V. Myllyla Cranio-caudal movements of the liver, pancreas and kidneys in respiration Acta Radiol Diagn (Stockh) 25 1984 129 131 (Pubitemid 14108143)
31. S.D. Goldstein, E.C. Ford, and M. Duhon Use of respiratory-correlated four-dimensional computed tomography to determine acceptable treatment margins for locally advanced pancreatic adenocarcinoma Int J Radiat Oncol Biol Phys 76 2010 597 602
32. S. Mori, R. Hara, and T. Yanagi Four-dimensional measurement of intrafractional respiratory motion of pancreatic tumors using a 256 multi-slice CT scanner Radiother Oncol 92 2009 231 237
33. L. Kivisaari, P. Makela, and M. Aarimaa Pancreatic mobility: An important factor in pancreatic computed tomography J Comput Assist Tomogr 6 1982 854 856 (Pubitemid 12097843)
34. X. Zhu, J.D. Bourland, and Y. Yuan Tradeoffs of integrating real-time tracking into IGRT for prostate cancer treatment Phys Med Biol 54 2009 N393 N401
35. T.R. Willoughby, P.A. Kupelian, and J. Pouliot Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer Int J Radiat Oncol Biol Phys 65 2006 528 534
36. P. Kupelian, T. Willoughby, and A. Mahadevan Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy Int J Radiat Oncol Biol Phys 67 2007 1088 1098